Lumida
/GSK
⌘K
GSK plc

GSK plc

GSK
$48.13USD+0.02%+0.01 today

MARKET CAP

52.6B

P/E (TTM)

FWD P/E

DAY RANGE

$48 – $49

52W RANGE

$39
$62
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$33.4B$35.5B$38.6B$39.4B$43.9B
YoY %+6.6%+6.3%+8.8%+2.0%+11.6%
P / Sales4.5x3.6x3.7x3.4x4.6x
EV / Sales6.7x5.2x5.1x4.7x5.8x
Gross Profit, Adj.$22.4B$23.9B$27.7B$28.0B$31.8B
YoY %+5.8%+7.0%+15.8%+1.1%+13.5%
Margin %66.9%67.4%71.8%71.2%72.4%
EV / Gross Profit10.0x7.6x7.1x6.7x8.1x
EBITDA, Adj.$6.0B$7.8B$8.6B$5.0B$10.7B
YoY %+11.4%+29.5%+10.3%-41.2%+111.4%
Margin %18.0%21.9%22.2%12.8%24.3%
EV / EBITDA37.3x23.5x22.8x37.0x24.0x
EBIT$6.0B$7.8B$8.6B$5.0B$10.7B
YoY %+11.4%+29.5%+10.3%-41.2%+111.4%
Margin %18.0%21.9%22.2%12.8%24.3%
EV / EBIT37.3x23.5x22.8x37.0x24.0x
Net Income$4.8B$18.1B$6.3B$3.2B$7.7B
YoY %-42.1%+280.6%-65.3%-48.5%+137.9%
Net Margin14.2%51.0%16.2%8.2%17.5%
EPS (GAAP)$1.17$4.43$1.53$0.78$1.87
YoY %-43.2%+278.6%-65.5%-49.0%+139.7%